MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Graves Ophthalmopathy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Graves Disease < Graves Ophthalmopathy < Greece  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000115 (2020) Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.
000438 (2019) Diego Strianese [Arabie saoudite] ; Francesca Rossi [Italie]Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.
000515 (2019) Anna Leszczynska [Espagne] ; Blanca Molins [Espagne] ; Estrella Fernández [Espagne] ; Alfredo Adán [Espagne] ; Santiago Ortiz-Perez [Espagne]Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab.
000520 (2019) Natalia Genere [États-Unis] ; Marius N. Stan [États-Unis]Current and Emerging Treatment Strategies for Graves' Orbitopathy.
000645 (2018) Shirin Hamed Azzam ; Swan Kang ; Mario Salvi ; Daniel G. EzraTocilizumab for thyroid eye disease.
000654 (2018) I. Pascual-Camps [Espagne] ; R. Molina-Pallete [Espagne] ; M A Bort-Martí [Espagne] ; J. Todolí [Espagne] ; E. Espa A-Gregori [Espagne]Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
000685 (2018) Carlos A. Canas [Colombie] ; Fabio Bonilla-Abadia [Colombie] ; Katherine Vallejo [Colombie] ; Hector M. Rengifo [Colombie] ; Marco A. Gallon [Colombie] ; Gabriel J. Tobon [Colombie]Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab.
000718 (2018) L. De-Pablo-G Mez-De-Lia O [Espagne] ; J I Fernández-Vigo [Espagne] ; J. Troyano-Rivas [Espagne] ; C. Ni O-Rueda [Espagne] ; Á Romo-L Pez [Espagne] ; R. G Mez-De-Lia O [Espagne]Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
000840 (2018) Jose V. Perez-Moreiras [Espagne] ; Juan J. Gomez-Reino [Espagne] ; Jose R. Maneiro [Espagne] ; Eva Perez-Pampin [Espagne] ; Angel Romo Lopez [Espagne] ; Fernando M. Rodríguez Alvarez [Espagne] ; Jesús M. Castillo Laguarta [Espagne] ; Aurora Del Estad Cabello [Espagne] ; María Gessa Sorroche [Espagne] ; Enrique Espa A Gregori [Espagne] ; Marco Sales-Sanz [Espagne]Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
000877 (2018) Anupam Kotwal [États-Unis] ; Marius Stan [États-Unis]Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy.
000921 (2018) Rashmi Kumari [Inde] ; Bhawesh Chandra Saha [Inde]Advances in the management of thyroid eye diseases: An overview.
000C38 (2017) Wilmar M. Wiersinga [Pays-Bas]Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
000D29 (2016) Irene Campi [Italie] ; Guia Vannucchi [Italie] ; Mario Salvi [Italie]THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.
000D92 (2016) Poupak Fallahi [Italie] ; Silvia Martina Ferrari [Italie] ; Giusy Elia [Italie] ; Francesco Nasini [Italie] ; Michele Colaci [Italie] ; Dilia Giuggioli [Italie] ; Roberto Vita [Italie] ; Salvatore Benvenga [Italie] ; Clodoveo Ferri [Italie] ; Alessandro Antonelli [Italie]Novel Therapies for Thyroid Autoimmune Diseases.
001066 (2015) M. Salvi [Italie] ; I. Campi [Italie]Medical Treatment of Graves' Orbitopathy.
001224 (2014) Lourdes G Mez Rodríguez [Oman] ; Manuel Jesús Cárdenas Aranzana [Espagne] ; Carmen Avilés Mora [Oman][Effectiveness and safety of tocilizumab in corticoid refractory Graves' Orbitopathy].
001347 (2014) Mario Salvi [Italie]Immunotherapy for Graves' ophthalmopathy.
001B29 (2008) Daniel El Fassi [Danemark] ; Claus Henrik Nielsen ; Laszlo Hegedüs[Biological treatment options for Graves' ophthalmopathy].
001C48 (????) Thomas Copperman [États-Unis] ; Oluwatobi O. Idowu ; Robert C. Kersten ; M Reza VagefiSubcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery.
001C75 (????) Diego Strianese [Italie]Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease.
001C96 (????) Aileen Sy [États-Unis] ; Kasra Eliasieh ; Rona Z. SilkissClinical Response to Tocilizumab in Severe Thyroid Eye Disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Graves Ophthalmopathy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Graves Ophthalmopathy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Graves Ophthalmopathy
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021